WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


Primary Election Day
Severe Weather Threat for Lakes Region Increases for Wednesday, Friday
Harrison Man Charged After Pursuit in Baxter County
Rainy Pattern in Place, Severe Storms Possible Later This Week
Early Voting Last Day, Primary Election Tuesday